IPP Bureau
Shilpa Medicare Analytical Services Division gets VAI status from USFDA after GMP inspection
By IPP Bureau - May 23, 2023
This is the second US FDA GMP inspection of this facility within one year
Sun Pharma Advanced Research Company posts Q4 FY23 loss at Rs. 81.99 Cr
By IPP Bureau - May 23, 2023
The company has reported total income of Rs. 58.42 crores during the period ended March 31, 2023
Agilent to appeal patent office decision on CRISPR gRNA patents
By IPP Bureau - May 23, 2023
Agilent respectfully disagrees with the PTAB’s opinion of unpatentability in view of prior art previously considered by the USPTO during its primary examination
Freenome acquires global immunodiagnostics developer Oncimmune
By IPP Bureau - May 23, 2023
Acquisition enhances Freenome's product portfolio, including autoantibody platform with additional biomarkers important in cancer detection
Roche introduces navify sample tracking for labs to track patient test samples
By IPP Bureau - May 23, 2023
navify Sample Tracking is part of the navify Diagnostics portfolio, a set of digital solutions enabling labs to drive end-to-end operational excellence across care settings.
Anuh Pharma posts Q4 FY23 PAT at Rs. 9.62 Cr
By IPP Bureau - May 22, 2023
Anuh Pharma has reported total income of Rs. 158.34 crores during the period ended March 31, 2023
Zydus receives final approval from the USFDA for Ephedrine Sulfate Injection
By IPP Bureau - May 22, 2023
Ephedrine Sulfate Injection USP, 50 mg/mL had annual sales of USD 52 mn in the United States
Eris Lifesciences posts consolidated Q4FY23 PAT at Rs. 65.41 Cr
By IPP Bureau - May 22, 2023
Eris Lifesciences has reported total income of Rs. 403.80 crores during the period ended March 31, 2023
Zydus Wellness' FY23 consolidated net sales up 12.8% at Rs. 2243 Cr
By IPP Bureau - May 22, 2023
Glucon-D, Sugar Free, EverYuth Scrub, Peel Off Face Mask and Nycil maintained their leadership positions in their respective categories as on March 2023
GlaxoSmithKline Pharmaceuticals posts consolidated Q4 FY2023 PAT at Rs. 133.43 Cr
By IPP Bureau - May 22, 2023
The company has reported total income of Rs. 815.11 crores during the period ended March 31, 2023
Mandaviya to inaugurate conference on 'India Pharma & India Medical Devices’ on May 26-27
By IPP Bureau - May 22, 2023
8th Edition of the event to promote India as a manufacturing hub of quality medical products in the Pharmaceutical and Medical Devices Sector
Modi addresses 76th session of the World Health Assembly in Geneva virtually
By IPP Bureau - May 22, 2023
India’s efforts are aimed at boosting health at the last mile
Croda signs supply deals with Amyris, BSI for vaccine adjuvants
By IPP Bureau - May 21, 2023
These announcements are in line with Croda Pharma’s strategy to “Empower Biologics Delivery” and follows news on investments, earlier this year, to expand Croda Pharma’s global manufacturing capabilities to enable the next generation vaccines and therapeutic drugs.
Abbott India posts Q4FY23 PAT at Rs. 231.42 Cr
By IPP Bureau - May 20, 2023
The company has reported total income of Rs. 1392.72 crores during the period ended March 31, 2023
Alkem Laboratories posts Q4 FY23 consolidated PAT slides to Rs. 70.98 Cr
By IPP Bureau - May 20, 2023
The company has reported total income of Rs. 2971.27 crores during the period ended March 31, 2023
